Inhibitions of urinary oxidative stress and renal calcium level by an extract of Quercus salicina Blume/Quercus stenophylla Makino in a rat calcium oxalate urolithiasis model

International Journal of Urology

Volumn 16, Issue 4, 2009, Pages 397-401

  Moriyama, Manabu T ^a   Suga, Koudai ^a   Miyazawa, Katsuhito ^a   Tanaka, Tatsuro ^a   Higashioka, Masaya ^b   Noda, Kumiko ^b   Oka, Michiko ^b   Tanaka, Mitsushi ^b   Suzuki, Koji ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

Antioxidative activity; Calcium oxalate; Quercus salicina Blume Quercus stenophylla Makino; Stone formation; Urolithiasis

Indexed keywords

ALFACALCIDOL; ANTIOXIDANT; CALCIUM; CALCIUM OXALATE; COLECALCIFEROL; ETHYLENE GLYCOL; MALONALDEHYDE; PLANT EXTRACT; UNCLASSIFIED DRUG; UROCALUN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; FLUID INTAKE; FOOD INTAKE; MALE; NONHUMAN; OAK; OXIDATIVE STRESS; PRIORITY JOURNAL; QUERCUS SALICINA BLUME; QUERCUS STENOPHYLLA MAKINO; RAT; URINALYSIS; URINE PH; URINE VOLUME; UROLITHIASIS;

ANIMALS; CALCIUM; CALCIUM OXALATE; DISEASE MODELS, ANIMAL; KIDNEY; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; QUERCUS; RATS; RATS, SPRAGUE-DAWLEY; UROLITHIASIS;

EID: 64549118683     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02268.x     Document Type: Article

References (17)

1. Park S. Medical management of urinary stone disease. Expert Opin. Pharmacother. 2007 8 : 1117 25.
2. Ahlstrand C, Tiselius HG. Recurrences during a 10-year follow-up after first renal stone episode. Urol. Res. 1990 18 : 397 9.
3. Thamilselvan S, Menon M. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status of calcium oxalate crystal attachment to injured renal collecting duct cells. BJU Int. 2005 96 : 117 26.
4. Natsukawa T, Hirata K, Noda K et al. Promoting effect of extract of Quercus salicina Blume/Q. stenophylla Makino (UROCALUN) on urinary stone passage. Jpn. Pharmacol. Ther. 2005 33 : 361 8.
5. Ishigami J, Ooshima H, Saitou H. Clinical effect of UROCALUN on urolithiasis in the upper urinary tract. Hifu to Hinyo 1967 29 : 858 62 In Japanese; Abstract in English K, Yamada S, Johsen T, Tanaka M. Uses of UC-2 for treatment of upper urinary calculi and studies on dissolution of urinary calculi by UC-2. Hifu to Hinyo 1967 30 : 426 31 In Japanese; Abstract in English MT, Miyazawa K, Noda K, Oka M, Tanaka M, Suzuki K. Reduction in oxalate-induced renal tubular epithelial cell injury by an extract from Quercus salicina Blume/Quercus stenophylla Makino. Urol. Res. 2007 35 : 295 300.
6. Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J. Urol. 2005 173 : 271 5.
7. Moriyama MT, Glenton PA, Khan SR. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J. Urol. 2001 165 : 1687 92.
8. Kumar S, Sigmon D, Miller T et al. A new model of nephrolithiasis involving tubular dysfunction/injury. J. Urol. 1991 146 : 1384 9.
9. Hackett RL, Shevock PN, Khan SR. Cell injury associated calcium oxalate crystalluria. J. Urol. 1990 144 : 1535 8.
10. Okada Y, Kawamura J, Nonomura M, Kuo YJ, Yoshida O. Experimental and clinical studies on calcium urolithiasis: (I) animal model for calcium oxalate urolithiasis using ethylene glycol and 1-alpha (OH) D3. Hinyokika Kiyo 1985 31 : 565 77 In Japanese; Abstract in English T, Sato M, Fujita K, Tozawa K, Nonura S, Kohri K. Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol. Res. 2001 29 : 50 6.
11. Chow K, Dixon J, Gilpin S, Kavanagh JP, Rao PN. Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones. Kidney Int. 2004 65 : 1724 30.
12. Moriyama MT, Domiki C, Miyazawa K, Tanaka T, Suzuki K. Effects of oxalate exposure on Madin-Darby canine kidney cells in culture: Renal prothrombin fragment-1 mRNA expression. Urol. Res. 2005 33 : 470 5.
13. Huang HS, Ma MC, Chen CF, Chen J. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 2003 62 : 1123 8.
14. Huang HS, Chen J, Chen CF, Ma MC. Vitamin E attenuate crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors. Kidney Int. 2006 70 : 699 710.
15. Thamilselvan S, Byer KJ, Hackett RL, Khan SR. Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J. Urol. 2000 164 : 224 9.
16. Jeong BC, Kim BS, Kim JI, Kim HH. Effects of green tea on urinary stone formation: An in vivo and in vitro study. J. Endourol. 2006 20 : 356 61.
17. Selvam R. Calcium oxalate stone disease: Role of lipid peroxidation and antioxidants. Urol. Res. 2002 30 : 35 47.